Hepatocellular carcinoma (HCC) is a highly aggressive and lethal malignancy with limited treatment options. Despite significant advancements in drug development for HCC, the high cost of therapy remains a major challenge for patients and healthcare systems globally. Balancing efficacy and cost in HCC drug treatment is crucial to ensure that patients receive optimal therapy while also managing...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian